Completed Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules NCT01226316 Conditions AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more Locations Research Site — Los Angeles, California, United States Research Site — Stanford, California, United States Research Site — West Hollywood, California, United States Research Site — Aurora, Colorado, United States View all 34 locations View more locations Show fewer locations Loading locations... View Trial Details